Biggest News Aggregation in the World
📰 Bph News

Page 83 - Bph News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bph. Real-time updates on events, politics, business and more.

α-Blocker Treatment Linked to Worse Cardiovascular Outcomes in Patients With Benign Prostatic Hyperplasia

These new findings are important as α-blockers (ABs) are the most prescribed class of medications for patients with benign prostatic hyperplasia (BPH), but the cardiovascular safety profile of this treatment is not well understood for this patient population.
Medicare Advantage Benign Prostatic Hyperplasia α Blockers Alpha Blockers 5 α Reductase Inhibitors 5 Aris
Source: ajmc.com

Kemaman by-election: Terengganu BN pledges support for direct candidate

KUALA TERENGGANU: Terengganu Barisan Nasional (BN) has unanimously pledged its support for General (Rtd) Tan Sri Raja Mohamed Affandi Raja Mohamed Noor who was named on Monday (Nov 13) as the coalition’s direct candidate for the Kemaman parliamentary by-election, slated for Dec 2.
Kuala Terengganu Terengganu Barisan Nasional Raja Mohamed Affandi Terengganu Pakatan Harapan Terengganu Election Court Election Commission

Kingswood Wealth Advisors LLC Makes New $3.94 Million Investment in Parker-Hannifin Co. (NYSE:PH)

Kingswood Wealth Advisors LLC acquired a new position in Parker-Hannifin Co. (NYSE:PH – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,100 shares of the industrial products company’s stock, valued at approximately $3,939,000. Parker-Hannifin makes up about 1.3% of Kingswood Wealth […]
Stifel Nicolaus Joseph Scaminace Robertw Baird Toddm Leombruno Parker Hannifin Company Profile Securities Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Early Use of ctDNA May Accelerate Time to Treatment and Improve Survival in NSCLC

While there are considerable barriers to incorporating comprehensive genotyping, the use of circulating tumor DNA offers an improvement in molecular testing—and doing so earlier can accelerate the time to treatment and improve survival for patients with lung cancer.
New York United States Leslyem Heisler Charu Aggarwal University Of Pennsylvania Physician Education Resource

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science